Covered recipient · General Payments record
MARK BRADFORD
General Payments · PY2018–2022
$4,809.93
- Reported across 330 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $220.69 | 13 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $55.08 | 3 |
| Acerta Pharma LLC | $35.10 | 2 |
| DEXCOM, INC. | $33.72 | 2 |
| ABBVIE INC. | $29.12 | 2 |
| Novo Nordisk AS | $28.79 | 2 |
| Xeris Pharmaceuticals, Inc. | $21.46 | 1 |
| Antares Pharma, Inc. | $17.42 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (13)
Sorted by paying entity, then date · as published by CMS
Program year 2022 2018201920202021
Record-level detail is published for PY2022; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.40 | 02/11/2022 | Food and Beverage | Undisputed | 01/23/2026 | 890648389 | CMS |
| ABBVIE INC. | $13.72 | 03/21/2022 | Food and Beverage | Undisputed | 01/23/2026 | 890648391 | CMS |
| Antares Pharma, Inc. | $17.42 | 02/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | 956816318 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.54 | 03/03/2022 | Food and Beverage | Undisputed | 01/23/2026 | 920237559 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.56 | 03/10/2022 | Food and Beverage | Undisputed | 01/23/2026 | 920234155 | CMS |
| Dexcom, Inc. | $12.14 | 01/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | 957405449 | CMS |
| Dexcom, Inc. | $21.58 | 03/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 957405451 | CMS |
| Novo Nordisk Inc | $11.96 | 02/18/2022 | Food and Beverage | Undisputed | 01/23/2026 | 899375883 | CMS |
| Novo Nordisk Inc | $16.83 | 03/23/2022 | Food and Beverage | Undisputed | 01/23/2026 | 899022705 | CMS |
| SANOFI-AVENTIS U.S. LLC | $19.69 | 01/18/2022 | Food and Beverage | Undisputed | 01/23/2026 | 938745227 | CMS |
| SANOFI-AVENTIS U.S. LLC | $14.61 | 02/15/2022 | Food and Beverage | Undisputed | 01/23/2026 | 938745243 | CMS |
| SANOFI-AVENTIS U.S. LLC | $20.78 | 03/04/2022 | Food and Beverage | Undisputed | 01/23/2026 | 938745241 | CMS |
| Xeris Pharmaceuticals, Inc. | $21.46 | 01/10/2022 | Food and Beverage | Undisputed | 01/23/2026 | 946484753 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.